Pharmacist Evaluating Exam study materials
Pharmacist Evaluating Exam study resources

New Beta-Blocker in a Patient With Worsening Asthma

Pharmacist Evaluating Exam · Put your knowledge to work in context.

All case studies

New Beta-Blocker in a Patient With Worsening Asthma

Mrs. K is a 62-year-old woman with moderate persistent asthma. She takes budesonide/formoterol 200/6 mcg two puffs BID and salbutamol as needed. Today she presents to the community pharmacy with a new prescription for metoprolol 50 mg BID from a walk-in clinic for stage 2 hypertension. She reports two days of worsening wheeze and cough. She has used her salbutamol inhaler six times in the past 24 hours and woke twice overnight with shortness of breath. Her peak expiratory flow is 60% of her personal best. Heart rate is 98, respiratory rate 24, and oxygen saturation is 94% on room air. She says her chest feels tight. She drove herself to the pharmacy and is asking whether she can start the metoprolol now because her blood pressure was high at the clinic.

1. What is your priority action right now and why?

Read the worked answer
  • The priority is the asthma exacerbation, not the new prescription. Peak flow at 60% of personal best, nocturnal awakenings, salbutamol use six times in 24 hours, RR 24, and SpO2 94% indicate a moderate-to-severe exacerbation.
  • She needs urgent medical assessment. Do not let her drive herself; call emergency services or arrange immediate transport to an emergency department or urgent care.
  • If the pharmacy has a salbutamol inhaler available and protocol allows, assist her in using it while waiting for transport, and monitor her.
  • Defer counseling about metoprolol until she is stable.

2. What are the concerns about metoprolol in this patient, and what alternatives would you recommend to the prescriber?

Read the worked answer
  • Metoprolol is cardioselective, but selectivity is dose-dependent and can be lost at higher doses. Beta-blockade can cause bronchoconstriction and blunt the response to salbutamol, especially during an acute exacerbation.
  • In asthma, beta-blockers should be avoided when possible. If a beta-blocker is essential, a cardioselective agent at the lowest dose with caution may be considered, but not during an acute exacerbation.
  • Recommend alternatives to the prescriber: an ACE inhibitor or ARB (monitor for cough and angioedema), a dihydropyridine calcium channel blocker such as amlodipine, or a thiazide-like diuretic.
  • Address asthma control first; uncontrolled asthma increases risk from any beta-blocker.

3. How would you respond if she insists on taking metoprolol today?

Read the worked answer
  • Explain that starting metoprolol now could worsen her breathing and that her current symptoms need urgent assessment.
  • Do not dispense the metoprolol without contacting the prescriber. If the prescriber confirms that a beta-blocker is necessary, document the risk-benefit discussion and start at a low dose only after the exacerbation is treated, with a clear asthma action plan.
  • If she insists, acknowledge her concern but maintain the safety recommendation; offer to contact the prescriber and help arrange transport.
  • Document the encounter.